Hookworms: George Washington University receives $2 million for phase 1 clinical trial to test vaccine
by Press Release from Outbreak News Today on (#1ERXE)
Phase 1 clinical trial to test a hookworm vaccine to occur in endemic area of Brazil Researchers from the George Washington University (GW) School of Medicine and Health Sciences received a $2.1 million U01 grant from the National Institutes of Health (NIH) to begin work on a phase 1 clinical trial to test a hookworm vaccine ["]
